The L. GLOBOCAN 2018: counting the toll of cancer. Lancet (London, England). 2018;392(10152):985.

Article  Google Scholar 

WHO: Global Action Plan for the Prevention and Control of NCDs 2013–2020. 2013.

Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928–43.

Article  CAS  PubMed  Google Scholar 

Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (London, England). 2009;374(9686):301–14.

Article  CAS  PubMed  Google Scholar 

Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J Natl Cancer Inst. 2020;112(2):145–53.

Article  PubMed  Google Scholar 

Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Global Burden of Disease Cancer C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.

Article  PubMed  Google Scholar 

Berthet N, Berling C, Nabi H, Woto Gaye G, Toure Kane C, Diop-Ndiaye H, Koumakpayi IH, Engohan Aloghe C, Bisvigou U, Didi Coulibaly J, et al. COFAC-Col: a cervical cancer control networking initiative in five French-speaking African countries. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2016;25(6):1004–5.

Article  Google Scholar 

Santé Mdl: Plan National de Développement Sanitaire (2019). Accessed 01 Aug 2019.

Moussavou PB, Koumakpayi IH, Nkili-Meyong AA, Labouba I, Bisvigou U, Chansi JK, Engohan-Aloghe C, Dissanami F, Ambounda N, Delannoy-Vieillard A-S, et al. Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol’s iodine (VIA/VILI) in Libreville, Gabon. Infect Agents Cancer. 2016;11(1):50.

Article  Google Scholar 

Zoa Assoumou S, Ndjoyi Mbiguino A, Mabika Mabika B, Nguizi Ogoula S, El Mzibri M, Khattabi A, Ennaji MM. Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities. Infect Agents Cancer. 2016;11:2.

Article  Google Scholar 

Zoa-Assoumou S, Ndjoyi-Mbiguino A, Mabika BM, Belembaogo E, Khattabi A, Ennaji MM. Human papillomavirus genotypes distribution in cervical cancer cases in Gabon. Infect Agents Cancer. 2016;11:42.

Article  Google Scholar 

Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet Off Org Int Fed Gynaecol Obstet. 2009;105(2):107–8.

Article  Google Scholar 

Schmitz M, Scheungraber C, Herrmann J, Teller K, Gajda M, Runnebaum IB, Durst M. Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2009;44(4):302–7.

Article  CAS  Google Scholar 

Eom J-H, Park S-B, Zhang B-T. Genetic mining of DNA sequence structures for effective classification of the risk types of human papillomavirus (HPV). In: International Conference on Neural Information Processing. Springer; 2004. p. 1334–1343.

Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16:29.

Article  PubMed  PubMed Central  Google Scholar 

Les tests au cœur de la stratégie de riposte contre la COVID-19 au Gabon. https://www.afro.who.int/fr/news/les-tests-au-coeur-de-la-strategie-de-riposte-contre-la-covid-19-au-gabon (2020). Accessed 26 May 2022.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.

Article  CAS  PubMed  Google Scholar 

Xing B, Guo J, Sheng Y, Wu G, Zhao Y. Human papillomavirus-negative cervical cancer: a comprehensive review. Front Oncol. 2020;10: 606335.

Article  PubMed  Google Scholar 

Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological S, Barretos Cancer H, Baylor College of M, Beckman Research Institute of City of H, Buck Institute for Research on A, Canada's Michael Smith Genome Sciences C, Harvard Medical S, Helen FGCC et al: Integrated genomic and molecular characterization of cervical cancer. Nature 2017, 543(7645):378–384.

Nkili-Meyong AA, Moussavou-Boundzanga P, Labouba I, Koumakpayi IH, Jeannot E, Descorps-Declere S, Sastre-Garau X, Leroy EM, Belembaogo E, Berthet N. Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology. Sci Rep. 2019;9(1):1504.

Article  PubMed  PubMed Central  Google Scholar 

Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, et al. One virus, one lesion–individual components of CIN lesions contain a specific HPV type. J Pathol. 2012;227(1):62–71.

Article  CAS  PubMed  Google Scholar 

Pirek D, Petignat P, Vassilakos P, Gourmaud J, Pache JC, Rubbia-Brandt L, Sando Z, McKee TA, Ho L. Human papillomavirus genotype distribution among Cameroonian women with invasive cervical cancer: a retrospective study. Sex Transm Infect. 2015;91(6):440–4.

Article  PubMed  Google Scholar 

Diop-Ndiaye H, Sastre-Garau X, Drame A, Dembele B, Ba NN, Diop-Diongue O, Mbow M, Diakhaby MEB, Woto-Gaye G, Toure Kane C, et al. Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal. J Med Virol. 2021;93(8):5110–7.

Article  CAS  PubMed  Google Scholar 

Maranga IO, Hampson L, Oliver AW, Gamal A, Gichangi P, Opiyo A, Holland CM, Hampson IN. Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS ONE. 2013;8(10): e78411.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24(Suppl 3):11–25.

Article  Google Scholar